Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of molecular medicine

• Publication date

  2012-01-10

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s00109-011-0856-xPMID 22231745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths

  2012cited by this paper
• The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus

  2011cited by this paper
• Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes

  2011cited by this paper
• Cancer statistics, 2011

  2011cited by this paper
• Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy

  2011cited by this paper
• Oxidative stress and oxidative damage in chemical carcinogenesis.

  2011cited by this paper
• Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab

  2010cited by this paper
• Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms.

  2010cited by this paper
• Anti-proliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cells

  2010cited by this paper
• Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.

  2010cited by this paper
• Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability

  2010cited by this paper
• Cannabinoids and the gut: new developments and emerging concepts.

  2010cited by this paper
• Inflammation and colon cancer.

  2010cited by this paper
• THEMED ISSUE: CANNABINOIDS RESEARCH PAPER The effects of D-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitisbph_791 712..723

  2010cited by this paper
• Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

  2009influential reference
• Colon cancer: preventive agents and the present status of chemoprevention

  2009cited by this paper
• Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.

  2009influential reference
• Cannabinoids in intestinal inflammation and cancer.

  2009cited by this paper
• Molecular origins of cancer: Molecular basis of colorectal cancer.

  2009cited by this paper
• Emerging strategies for exploiting cannabinoid receptor agonists as medicines

  2009cited by this paper
• Time-dependent vascular actions of cannabidiol in the rat aorta.

  2009influential reference
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.

  2008cited by this paper
• Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α–Mediated Ceramide De novo Synthesis in Colon Cancer Cells

  2008cited by this paper
• Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses β-catenin-dependent transcription

  2008cited by this paper
• Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice

  2008cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• The cannabinoid δ9‐tetrahydrocannabinol inhibits RAS‐MAPK and PI3K‐AKT survival signalling and induces BAD‐mediated apoptosis in colorectal cancer cells

  2007cited by this paper
• Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon

  2007influential reference
• The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.

  2007cited by this paper
• Methods for determining the proliferation of cells in response to EGFR ligands.

  2006cited by this paper
• The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells

  2006cited by this paper
• Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma

  2006cited by this paper
• Recent advances in understanding the cell death pathways activated by anticancer therapy

  2005cited by this paper
• Nitric oxide signaling in colon cancer chemoprevention.

  2004cited by this paper
• Capsaicin, a Spicy Component of Hot Pepper, Induces Apoptosis by Activation of the Peroxisome Proliferator-Activated Receptor γ in HT-29 Human Colon Cancer Cells

  2004influential reference
• Possible endocannabinoid control of colorectal cancer growth.

  2003cited by this paper
• Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells

  2003cited by this paper
• Pathology of mouse models of intestinal cancer: consensus report and recommendations.

  2003cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.

  2003cited by this paper
• Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation.

  2001cited by this paper

• Recent Developments in Protein-Based Hydrogels for Advanced Drug Delivery Applications

  2026cites this paper
• Stereoselective Synthesis of Cannabidiol and its Unnatural Enantiomer to Evaluate Anxiolytic‐Like Properties and Memory Interactions

  2025cites this paper
• Cannabidiol (CBD) and Colorectal Tumorigenesis: Potential Dual Modulatory Roles via the Serotonergic Pathway

  2025cites this paper
• Revealing the therapeutic potential of synthetic cannabinoids: a systematic review of cannabinoid receptor binding dynamics and their implications for cancer therapy

  2025cites this paper
• Cannabinoids: Adaptogens or Not?

  2025cites this paper
• Genotoxic assessment of a Cannabis sativa L. extract

  2025cites this paper
• The key role of natural products in the fight against endometrial Cancer.

  2025cites this paper
• The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology

  2025cites this paper
• Unlocking the potential: Cannabidiol (CBD) as a promising anti-tumor agent.

  2025cites this paper
• Cannabidiol Targets Colorectal Cancer Cells via Cannabinoid Receptor 2, Independent of Common Mutations.

  2025cites this paper
• Development and In Vitro Kinetic Evaluation of PEG-Chitosan Biohybrid Micelles loading CBD with Bile Acid/Quercetin as Surface Modifiers for Colon Cancer Therapy.

  2025cites this paper
• Targeting Human Cancer Cells with Cannabidiol (CBD): Apoptotic Cytotoxicity in HeLa, MDA-MB-231, and CaCo-2 Lines

  2025influential citation
• Optimization of pH-responsive cannabidiol-loaded polyhydroxybutyrate/cellulose acetate phthalate microparticles using response surface methodology for anticancer properties.

  2025cites this paper
• The effects of cannabidiol on nitric oxide synthases: a narrative review on therapeutic implications for inflammation and oxidative stress in health and disease

  2025cites this paper
• Potential Anti-Tumorigenic Properties of Diverse Medicinal Plants against the Majority of Common Types of Cancer

  2024cites this paper
• A Novel Non-Psychoactive Fatty Acid from a Marine Snail, Conus inscriptus, Signals Cannabinoid Receptor 1 (CB1) to Accumulate Apoptotic C16:0 and C18:0 Ceramides in Teratocarcinoma Cell Line PA1

  2024cites this paper
• Diurnal and circadian regulation of opsin-like transcripts in the eyeless cnidarian Hydra

  2024cites this paper
• The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD

  2024cites this paper
• Cannabidiol activates MAPK pathway to induce apoptosis, paraptosis, and autophagy in colorectal cancer cells

  2024cites this paper
• Preliminary In Vitro Assessment of Whey Protein Isolate Hydrogel with Cannabidiol as a Potential Hydrophobic Oral Drug Delivery System for Colorectal Cancer Therapy

  2024cites this paper
• Exploring Endocannabinoid System: Unveiling New Roles in Modulating ER Stress

  2024cites this paper
• Discovery of Ring-Annulated Analogues of Cannabidiol as Potential Anticancer Agents: Synthesis and Biological Evaluation.

  2024cites this paper
• DNA damage and cell death in human oral squamous cell carcinoma cells: The potential biological effects of cannabidiol.

  2024cites this paper
• Cannabis for medicine and food: A benefit vs risk critical appraisal

  2024cites this paper
• Exploring the Potential of Synthetic Cannabinoids: Modulation of Biological Activity of Normal and Cancerous Human Colon Epithelial Cells

  2024cites this paper
• Genotoxicity of selected cannabinoids in human lymphoblastoid TK6 cells

  2024cites this paper
• Cannabidiol Enhances the Anticancer Activity of Etoposide on Prostate Cancer Cells

  2024cites this paper
• In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities

  2024cites this paper
• Employee health and corporate innovation: Evidence from medical cannabis legalisation

  2024cites this paper
• Exploring the safety of cannabidiol (CBD): A comprehensive in vitro evaluation of the genotoxic and mutagenic potential of a CBD isolate and extract from Cannabis sativa L.

  2024cites this paper
• Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective

  2024cites this paper
• Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer

  2024influential citation
• Should oncologists trust cannabinoids?

  2023cites this paper
• Treatment of malignant diseases with phytocannabinoids: promising observations in animal models and patients

  2023cites this paper
• Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds

  2023cites this paper
• Cannabidiol - Help and hype in targeting mucosal diseases.

  2023cites this paper
• Characterization of the Chemopreventive Properties of Cannabis sativa L. Inflorescences from Monoecious Cultivars Grown in Central Italy

  2023cites this paper
• Exploring potential anti-inflammatory effects of medicinal cannabis

  2023cites this paper
• Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications

  2023cites this paper
• Cannabidiol Inhibits the Proliferation and Invasiveness of Prostate Cancer Cells

  2023cites this paper
• Research Progress of TRPV1 in Malignant Tumors of the Digestive System

  2023cites this paper
• An evaluation of the genotoxicity and 90‐day repeated‐dose toxicity of a CBD‐rich hemp oil

  2023cites this paper
• Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns

  2023cites this paper
• Therapeutic targeting of the tumor microenvironments with cannabinoids and their analogs: Update on clinical trials.

  2023cites this paper
• Antitumor Effects of Cannabis sativa Bioactive Compounds on Colorectal Carcinogenesis

  2023cites this paper
• Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications

  2023cites this paper
• Cannabidiol goes nuclear: The role of PPARγ.

  2023cites this paper
• Establishment of a Point of Departure for CBD Hepatotoxicity Employing Human HepaRG Spheroids.

  2023cites this paper
• Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model.

  2023cites this paper
• Curcumin Combats Against Gastrointestinal Cancer: A Review of Current Knowledge Regarding Epigenetics Mechanisms with a Focus on DNA Methylation.

  2023cites this paper
• Synthesis of a novel nanobioconjugate for targeted photodynamic therapy of colon cancer enhanced with cannabidiol

  2022cites this paper
• Valorization of Wild-Type Cannabis indica by Supercritical CO2 Extraction and Insights into the Utilization of Raffinate Biomass

  2022cites this paper
• Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells.

  2022cites this paper
• Disorders of cancer metabolism: The therapeutic potential of cannabinoids.

  2022cites this paper
• Photodynamic Therapy Efficacy of Novel Zinc Phthalocyanine Tetra Sodium 2-Mercaptoacetate Combined with Cannabidiol on Metastatic Melanoma

  2022cites this paper
• Use of Cannabis and Cannabinoids for Treatment of Cancer

  2022influential citation
• Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges

  2022cites this paper
• The Cytotoxic Effect of Isolated Cannabinoid Extracts on Polypoid Colorectal Tissue

  2022cites this paper
• Anti-Cancer Activity of Cannabis sativa Phytocannabinoids: Molecular Mechanisms and Potential in the Fight against Ovarian Cancer and Stem Cells

  2022cites this paper
• Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

  2022influential citation
• Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells.

  2022cites this paper
• Pharmacological effects of cannabidiol by transient receptor potential channels.

  2022cites this paper
• Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges

  2022cites this paper
• Plant-derived cannabinoids as anticancer agents.

  2022cites this paper
• Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics

  2022cites this paper
• A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)

  2022cites this paper
• Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization

  2022cites this paper
• Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System

  2021influential citation
• Evaluation of the Effects of Cannabis on Cell Growth of Stem Cells Derived from Endometrial Tissue of Uterine Rats

  2021cites this paper
• Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches

  2021cites this paper
• Genotoxicity of Marijuana in Mono-Users

  2021cites this paper
• Cannabis: Chemistry, extraction and therapeutic applications.

  2021cites this paper
• Cannabidiol Induces Cell Death in Human Lung Cancer Cells and Cancer Stem Cells

  2021cites this paper
• In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin

  2021cites this paper
• Self-Assembly System Based on Cyclodextrin for Targeted Delivery of Cannabidiol

  2021cites this paper
• Cancer Therapy Challenge: It Is Time to Look in the “St. Patrick’s Well” of the Nature

  2021cites this paper
• The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology

  2021cites this paper
• In vitro Activity of Novel Cannabinoids Derived from Tetrahydrocannabinolic Acid on Various Human Tumor Cell Lines

  2021cites this paper
• Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy

  2021cites this paper
• Cannabinoids in the landscape of cancer

  2021cites this paper
• Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?

  2021cites this paper
• Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?

  2021cites this paper
• The Impact of TRPV1 on Cancer Pathogenesis and Therapy: A Systematic Review

  2021cites this paper
• Therapeutic potential of cannabinoids in combination cancer therapy.

  2021cites this paper
• The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer

  2020cites this paper
• Cannabidiol bei Tumorerkrankungen

  2020cites this paper
• The role of cannabinoids in the treatment of cancer.

  2020cites this paper
• The Endocannabinoid System: A Target for Cancer Treatment

  2020influential citation
• Safety Assessment of a Hemp Extract using Genotoxicity and Oral Repeat-Dose Toxicity Studies in Sprague-Dawley Rats

  2020cites this paper
• Developing Raman microspectroscopy as a technique to analyse single Caco-2 cell

  2020cites this paper
• Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol.

  2020cites this paper
• Cannabis sativa: much more beyond Δ9-tetrahydrocannabinol.

  2020cites this paper
• Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?

  2020cites this paper
• Cannabidiol on 5-FU-induced oral mucositis in mice.

  2020cites this paper
• Cannabinoid Effects on Experimental Colorectal Cancer Models Reduce Aberrant Crypt Foci (ACF) and Tumor Volume: A Systematic Review

  2020influential citation
• Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis

  2020influential citation
• Cannabidiol (CBD) as a Promising Anti-Cancer Drug

  2020cites this paper
• The pharmacological basis for application of cannabidiol in cancer chemotherapy

  2020cites this paper
• Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

  2020cites this paper
• Cannabinoides no psicoactivos en cáncer: estudios in vivo

  2020cites this paper